134 related articles for article (PubMed ID: 26941288)
1. Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain Proteins.
Nilsson LM; Green LC; Muralidharan SV; Demir D; Welin M; Bhadury J; Logan DT; Walse B; Nilsson JA
Cancer Res; 2016 Apr; 76(8):2376-83. PubMed ID: 26941288
[TBL] [Abstract][Full Text] [Related]
2. BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma.
Funck-Brentano E; Vizlin-Hodzic D; Nilsson JA; Nilsson LM
Epigenetics; 2021 Jan; 16(1):54-63. PubMed ID: 32603264
[TBL] [Abstract][Full Text] [Related]
3. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
Baldassarre G; Barone MV; Belletti B; Sandomenico C; Bruni P; Spiezia S; Boccia A; Vento MT; Romano A; Pepe S; Fusco A; Viglietto G
Oncogene; 1999 Nov; 18(46):6241-51. PubMed ID: 10597222
[TBL] [Abstract][Full Text] [Related]
4. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
5. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
6. [Differentiation effect of hexamethylene bisacetamide (HMBA) on mucoepidermoid carcinoma in vivo].
Jia B; Situ Z; Wu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Mar; 31(2):85-7. PubMed ID: 9387538
[TBL] [Abstract][Full Text] [Related]
7. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
8. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
9. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
10. Applying proteomic methodologies to analyze the effect of hexamethylene bisacetamide (HMBA) on proliferation and differentiation of human gastric carcinoma BGC-823 cells.
Zhang G; Wang G; Wang S; Li Q; Ouyang G; Peng X
Int J Biochem Cell Biol; 2004 Aug; 36(8):1613-23. PubMed ID: 15147739
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism underlying differentiation of HL-60 cells induced by hexamethylene bisacetamide].
Ren X; Wen PE; Yang WH; Tang TH; Ren HQ; Zhang ZY; Zhao HT; Fan H; Qiao GJ; Jiang GH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1030-4. PubMed ID: 18928589
[TBL] [Abstract][Full Text] [Related]
12. Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism.
Ketchart W; Yeh IJ; Zhou H; Thiagarajan PS; Lathia J; Reizes O; Exner A; Su B; Montano MM
Cancer Lett; 2016 Aug; 379(1):60-9. PubMed ID: 27238569
[TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
[TBL] [Abstract][Full Text] [Related]
14. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process.
Marks PA; Richon VM; Kiyokawa H; Rifkind RA
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10251-4. PubMed ID: 7937935
[TBL] [Abstract][Full Text] [Related]
15. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
Aroor AR; Singh LP; Wahba AJ
Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531
[TBL] [Abstract][Full Text] [Related]
16. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
17. [Effects of hexamethylene bisacetamide on cell cycle and expression of its regulatory proteins in HL-60 cells].
Wang QH; Xie Y; Fan HH; Gao L; Liu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):480-4. PubMed ID: 14575541
[TBL] [Abstract][Full Text] [Related]
18. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
Yamashita T; Eto Y; Shibai H; Ogata E
Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
[TBL] [Abstract][Full Text] [Related]
19. Hexamethylene bisacetamide (HMBA) increases thyroglobulin levels in porcine thyroid cells without increasing cyclic-AMP.
Aouani A; Samih N; Amphoux-Fazekas T; Mezghrani A; Mykhaylov S; Hovsépian S; Lombardo D; Fayet G
Horm Metab Res; 1999 Jul; 31(7):402-5. PubMed ID: 10450830
[TBL] [Abstract][Full Text] [Related]
20. Modulation effects of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells.
Li XN; Du ZW; Huang Q
J Neurosurg; 1996 May; 84(5):831-8. PubMed ID: 8622158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
